<DOC>
	<DOCNO>NCT01842997</DOCNO>
	<brief_summary>Since October 2009 , H1N1 influenza vaccine develop approve immunization population China . However , little epidemiological evidence safety vaccinate healthy pregnant woman . The main objective study assess safety split-virion inactivated H1N1 vaccine without adjuvant administer healthy pregnant woman . It stratify controlled clinical trial healthy pregnant woman . And participant include 226 healthy pregnant woman age 18 -35 year old history novel influenza H1N1 infection novel influenza H1N1 vaccination . The pregnancy week range 5 week 32 week . Subjects divide 2 group : vaccinate group（122） unvaccinated group（104） . Subjects vaccinate group administer one dose 15μg H1N1 vaccine . Subjects unvaccinated group receive vaccine control . Safety measure assessment pregnancy outcome . And observation time pregnancy outcomes last 28 day postpartum since vaccinate ; protective effect observe six month .</brief_summary>
	<brief_title>Safety H1N1 Influenza Vaccination Pregnant Women</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy pregnant woman 2 . Be able show legal identity card sake recruitment 3 . Be able understand sign inform consent 1 . Cases , cure case close contact influenza A ( H1N1 ) virus 2 . Subject medical history following : allergic history , allergic ingredient vaccine , egg , egg protein , etc 3 . Serious adverse reaction vaccine anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain 4 . Autoimmune disease immunodeficiency 5 . Asthma unstable require emergent care , hospitalization intubation past two year require use oral intravenous corticosteroid 6 . Diabetes mellitus ( type I II ) , exception gestational diabetes 7 . History thyroidectomy thyroid disease require medication within past 12 month 8 . Serious angioedema episode within previous 3 year require medication previous two year 9 . Bleeding disorder diagnose doctor ( e.g . factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draws 10 . Any history immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) 11 . History blood product seasonal influenza vaccine administration within 3 month dose 12 . Administration investigational research agent within 30 day dose 13 . Administration live attenuate vaccine within 30 day dose 14 . Administration subunit inactivate vaccine , e.g. , pneumococcal vaccine , allergy treatment antigen injection , within 14 day dose 15 . Axillary temperature &gt; 37.0 centigrade time dose 16 . Psychiatric condition precludes compliance protocol 17 . Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Flu</keyword>
	<keyword>non-adjuvanted H1N1 vaccine</keyword>
	<keyword>Safety</keyword>
	<keyword>pregnant woman</keyword>
</DOC>